The Effect of Probiotics on Gut Microbiota Modulation and Its Role in Mitigating Diabetes-Induced Hepatic Damage in Wistar Rats

The gut microbiota plays a crucial role in regulating health and mitigating diabetes-induced liver injury. This study evaluated the hepatoprotective effects of <i>Bifidobacterium bifidum</i> supplementation, both alone and in combination with metformin, in a rat model of diabetes-induced liver dysfunction. Rats were divided into six groups: control, probiotic only, metformin only, diabetic, diabetic with probiotic supplementation, and diabetic with combined probiotic and metformin treatment. Diabetes was induced using a single streptozotocin (STZ) injection following a 12 h fast. Probiotic supplementation (1 × 10<sup>9</sup> CFU/kg daily) was initiated 2 weeks before diabetes induction and continued throughout the experiment, while metformin was administered concurrently at a therapeutic dose. Weekly assessments included fasting blood glucose, insulin levels, glycation markers, and liver function tests. Both probiotic and metformin treatments significantly improved glycemic control (<i>p</i> < 0.05) and reduced fasting blood glucose levels (<i>p</i> < 0.01), with the combined therapy demonstrating the most pronounced effects. Additionally, insulin sensitivity was enhanced (<i>p</i> < 0.05), antioxidant enzyme levels were restored (<i>p</i> < 0.01), and histopathological analyses revealed preserved liver architecture, decreased inflammation (<i>p</i> < 0.01), and reduced fibrosis (<i>p</i> < 0.05). The Comet assay confirmed a significant reduction in DNA damage (<i>p</i> < 0.01), indicating the protective effects of the interventions against diabetes-induced hepatic injury. These findings highlight the potential of combining <i>Bifidobacterium bifidum</i> supplementation with metformin as a promising probiotic-based therapeutic approach for managing diabetes-related liver complications. Future studies are warranted to confirm these results and to optimize the long-term efficacy of probiotic interventions in diabetes management.

Authors

Institutions

Publication Details

Journal
Biology
Published
2025-03-22
DOI
https://doi.org/10.3390/biology14040323
Citations
4
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
3.22
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Effect of Probiotics on Gut Microbiota Modulation and Its Role in Mitigating Diabetes-Induced Hepatic Damage in Wistar Rats

Alaa Talal Qumsani
4 citations
Biology
Gut microbiota and health
3.22
article

The Effect of Probiotics on Gut Microbiota Modulation and Its Role in Mitigating Diabetes-Induced Hepatic Damage in Wistar Rats

Alaa Talal Qumsani
article en
4 citations

Abstract

The gut microbiota plays a crucial role in regulating health and mitigating diabetes-induced liver injury. This study evaluated the hepatoprotective effects of <i>Bifidobacterium bifidum</i> supplementation, both alone and in combination with metformin, in a rat model of diabetes-induced liver dysfunction. Rats were divided into six groups: control, probiotic only, metformin only, diabetic, diabetic with probiotic supplementation, and diabetic with combined probiotic and metformin treatment. Diabetes was induced using a single streptozotocin (STZ) injection following a 12 h fast. Probiotic supplementation (1 × 10<sup>9</sup> CFU/kg daily) was initiated 2 weeks before diabetes induction and continued throughout the experiment, while metformin was administered concurrently at a therapeutic dose. Weekly assessments included fasting blood glucose, insulin levels, glycation markers, and liver function tests. Both probiotic and metformin treatments significantly improved glycemic control (<i>p</i> < 0.05) and reduced fasting blood glucose levels (<i>p</i> < 0.01), with the combined therapy demonstrating the most pronounced effects. Additionally, insulin sensitivity was enhanced (<i>p</i> < 0.05), antioxidant enzyme levels were restored (<i>p</i> < 0.01), and histopathological analyses revealed preserved liver architecture, decreased inflammation (<i>p</i> < 0.01), and reduced fibrosis (<i>p</i> < 0.05). The Comet assay confirmed a significant reduction in DNA damage (<i>p</i> < 0.01), indicating the protective effects of the interventions against diabetes-induced hepatic injury. These findings highlight the potential of combining <i>Bifidobacterium bifidum</i> supplementation with metformin as a promising probiotic-based therapeutic approach for managing diabetes-related liver complications. Future studies are warranted to confirm these results and to optimize the long-term efficacy of probiotic interventions in diabetes management.

BiologyVol. 14(4)
Umm al-Qura University (SA)
Good health and well-being
Openalex Percentile: Top 9%
Gut microbiota and health
3.22
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.